Dr Andrew Michael Goldman, DO | |
106 Upper Main St, Sharon, CT 06069 | |
(860) 364-5990 | |
(860) 364-1366 |
Full Name | Dr Andrew Michael Goldman |
---|---|
Gender | Male |
Speciality | Neuromusculoskeletal Medicine & Omm |
Location | 106 Upper Main St, Sharon, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629114376 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Andrew Michael Goldman, DO 36 Green River Rd, Great Barrington, MA 01230-8901 Ph: (860) 364-5990 | Dr Andrew Michael Goldman, DO 106 Upper Main St, Sharon, CT 06069 Ph: (860) 364-5990 |
News Archive
Pall Corporation, a global leader in filtration, separation and purification, is refreshing its five-year plan originally presented to investors in October of 2008. The event will take place on December 17, 2009 from 9:00 a.m. to approximately 11:00 a.m. ET and is being webcast live.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
As clinical trial activity in the Asia Pacific region continues to expand and contract research organizations (CRO) increasingly provide sponsors with a range of strategic services and support, ACRONET joined the Medidata Partner Program to enhance its technology offerings across the clinical development process.
› Verified 2 days ago